These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 1245602)

  • 1. Blockade and stimulation of renal, adrenal, and vascular angiotensin II receptors with 1-Sar, 8-Ala angiotensin II in normal man.
    Hollenberg NK; Williams GH; Burger B; Ishikawa I; Adams DF
    J Clin Invest; 1976 Jan; 57(1):39-46. PubMed ID: 1245602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man.
    Hollenberg NK; Chenitz WR; Adams DF; Williams GH
    J Clin Invest; 1974 Jul; 54(1):34-42. PubMed ID: 4365595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin antagonists with increased specificity for the renal vasculature.
    Taub KJ; Caldicott WJ; Hollenberg NK
    J Clin Invest; 1977 Mar; 59(3):528-35. PubMed ID: 190270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of (des-Aspartyl1)-angiotensin II and angiotensin II in man. Differences in blood pressure and adrenocortical response during normal and low sodium intake.
    Carey RM; Vaughan ED; Peach MJ; Ayers CR
    J Clin Invest; 1978 Jan; 61(1):20-31. PubMed ID: 338631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of adrenal arterial infusion of saralasin (P113) on aldosterone secretion.
    Blair-West JR; Coghlan JP; Denton DA; Niall HD; Scoggins BA; Tregear GW
    Prog Biochem Pharmacol; 1976; 12():53-62. PubMed ID: 1019170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adrenal receptor for angiotensin II is altered in essential hypertension.
    Williams GH; Hollenberg NK; Moore TJ; Swartz SL; Dluhy RG
    J Clin Invest; 1979 Mar; 63(3):419-27. PubMed ID: 219037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal adrenal responsiveness and angiotensin II dependency in high renin essential hypertension.
    Dluhy RG; Bavli SZ; Leung FK; Solomon HS; Moore TJ; Hollenberg NK; Williams GH
    J Clin Invest; 1979 Nov; 64(5):1270-6. PubMed ID: 500810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of atrial natriuretic factor on blood pressure and the renin-angiotensin-aldosterone system.
    Atlas SA; Volpe M; Sosa RE; Laragh JH; Camargo MJ; Maack T
    Fed Proc; 1986 Jun; 45(7):2115-21. PubMed ID: 2940120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin as a renal, adrenal, and cardiovascular hormone: responses to saralasin in normal man and in essential and secondary hypertension.
    Hollenberg NK; Williams GH
    Kidney Int Suppl; 1979 Mar; (9):S29-35. PubMed ID: 384070
    [No Abstract]   [Full Text] [Related]  

  • 10. High renin activity accompanying angiotensin II inhibition in rats with ischemic renal failure.
    Shapira J; Iaina A; Eliahou HE; Solomon S
    Isr J Med Sci; 1976 Feb; 12(2):124-8. PubMed ID: 1262200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of sodium intake on vascular and adrenal angiotensin II receptors.
    Williams GH; Hollenberg NK; Braley LM
    Endocrinology; 1976 Jun; 98(6):1343-50. PubMed ID: 1278105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
    Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
    Prog Biochem Pharmacol; 1976; 12():230-41. PubMed ID: 1019166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonist and antagonist effects of Sar1-ala8--angiotensin II in salt-loaded and salt-depleted normal man.
    MacGregor GA; Dawes PM
    Br J Clin Pharmacol; 1976 Jun; 3(3):483-7. PubMed ID: 973974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased adrenal sensitivity to angiotensin II in low-renin essential hypertension.
    Wisgerhof M; Brown RD
    J Clin Invest; 1978 Jun; 61(6):1456-62. PubMed ID: 659608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between aldosterone and bradykinin.
    Mersey JH; Williams GH; Hollenberg NK; Dluhy RG
    Circ Res; 1977 May; 40(5 Suppl 1):I84-8. PubMed ID: 870233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1979 Apr; 63(4):727-35. PubMed ID: 438333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of prolonged and brief infusions of noradrenaline on arterial pressure and on the plasma concentrations of active renin, angiotensin II, aldosterone and potassium.
    Casals-Stenzel J; Tree M; Brown JJ; Fraser R; Lever AF; Millar JA; Morton JJ; Robertson JI; Reid JL; Hamilton C
    J Hypertens; 1983 Jun; 1(1):27-35. PubMed ID: 6397510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
    Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK
    Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II blockade and the functions of the renin-angiotensin system.
    Davis JO; Freeman RH; Watkins BE; Stephens GA; Williams GM
    Prog Biochem Pharmacol; 1976; 12():1-15. PubMed ID: 798202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders.
    Yamamoto T; Doi K; Ogihara T; Ichihara K; Hata T; Kumahara Y
    Prog Biochem Pharmacol; 1976; 12():174-89. PubMed ID: 1019163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.